Interim Review of Safety, Tolerability, and Efficacy From a First-In-Human Phase 1/2a Clinical Study of ICM-203, an Intra-Articular, AAV Gene Therapy for Osteoarthritis

被引：0
|
作者：
Heald, Alison E. [1 ,2 ]
Solomon, Bogdan [3 ]
Page, Richard [4 ,5 ]
Ahn, Yoenhee [1 ]
Yum, Young Na [1 ]
Myung, Jayhyuk [1 ]
Collins, Jamie E. [6 ]
Guermazi, Ali [7 ]
Kim, Dae-Won [1 ,8 ]
机构：
[1] ICM Co LTD, Seoul, South Korea
[2] Univ Washington, Sch Med, Seattle, WA USA
[3] Royal Adelaide Hosp, Adelaide, SA 5000, Australia
[4] Univ Hosp Geelong, Barwon Hlth, Geelong, Vic, Australia
[5] Deakin Univ, Geelong, Vic, Australia
[6] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[7] Boston Univ, Sch Med, Boston, MA 02118 USA
[8] Yonsei Univ, Seoul, South Korea
来源：
MOLECULAR THERAPY | 2024年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
146
引用
收藏
页码：80 / 80
页数：1
相关论文
共 42 条
  • [41] Efficacy and Safety at Week 52 and up to Four Years in Adults with Glycogen Storage Disease Type IA (GSDIa): Results from a Phase 1/2 Clinical Trial and Long-Term Follow-Up Study of DTX401, an AAV8-Mediated, Liver-Directed Gene Therapy
    Riba-Wolman, Rebecca
    Rodriguez-Buritica, David F.
    Ahmad, Ayesha
    Couce Pico, Maria-Luz
    Derks, Terry G.
    Mitchell, John
    Weinstein, David A.
    Mitragotri, Deepali
    Grimm, Andrew Alexander
    Crombez, Eric
    MOLECULAR THERAPY, 2023, 31 (04) : 2 - 3
  • [42] Safety and preliminary efficacy from the phase 1 portion of MasterKey-01: A First-in-human dose-escalation study to determine the recommended phase 2 dose (RP2D), pharmacokinetics (PK) and preliminary antitumor activity of BDTX-189, an inhibitor of allosteric ErbB mutations, in patients (pts) with advanced solid malignancies.
    Schram, Alison M.
    Ahnert, Jordi Rodon
    Patel, Manish R.
    Jauhari, Shekeab
    Sachdev, Jasgit C.
    Zhu, Viola Weijia
    LoRusso, Patricia
    Nguyen, Danny
    Le, Xiuning
    O'Connor, Matthew
    Waters, Nigel
    Cook, Carl
    Witt, Karsten
    Humphrey, Rachel W.
    Janne, Pasi A.
    Hamilton, Erika P.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345